Plain-English translation of NCT05940272 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a communication training program called Hematolo-GIST designed to help oncologists have better conversations with patients who have large B-cell lymphoma. The goal is to improve how doctors discuss diagnosis, treatment options, and advance care planning so that patients feel more heard and informed. Your participation would help researchers understand whether this training makes a real difference in the care experience.
Many patients with large B-cell lymphoma feel that conversations with their doctors about their diagnosis and future care could be improved. This study exists to test whether a new training program can help doctors communicate more effectively and compassionately with patients facing this serious illness.
You likely qualify if…
You likely don't qualify if…
As a patient participant, you would likely meet with your doctor who has received the special communication training, and you may be asked to share your thoughts about the conversation through surveys or interviews. The study involves doctors at Memorial Sloan Kettering who are caring for large B-cell lymphoma patients, and your participation would help researchers see whether the new training approach improves the patient experience.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States